ReviewCancers2023

Current Progress on Predictive Biomarkers for Response to Immune Checkpoint Inhibitors in Gastric Cancer: How to Maximize the Immunotherapeutic Benefit?

Yongqing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.